| Форма представления | Статьи в зарубежных журналах и сборниках |
| Год публикации | 2024 |
| Язык | русский |
|
Ларина Марина Леонидовна, автор
|
| Библиографическое описание на языке оригинала |
Ivanov A, Shamagsumova R, Larina M, Electrochemical Acetylcholinesterase Sensors for Anti-Alzheimer?s Disease Drug Determination//Biosensors. - 2024. - Vol.14, Is.2. - Art. №93.
|
| Аннотация |
Neurodegenerative diseases and Alzheimer's disease (AD), as one of the most common causes of dementia, result in progressive losses of cholinergic neurons and a reduction in the presynaptic markers of the cholinergic system. These consequences can be compensated by the inhibition of acetylcholinesterase (AChE) followed by a decrease in the rate of acetylcholine hydrolysis. For this reason, anticholinesterase drugs with reversible inhibition effects are applied for the administration of neurodegenerative diseases. Their overdosage, variation in efficiency and recommendation of an individual daily dose require simple and reliable measurement devices capable of the assessment of the drug concentration in biological fluids and medications. In this review, the performance of electrochemical biosensors utilizing immobilized cholinesterases is considered to show their advantages and drawbacks in the determination of anticholinesterase drugs. In addition, common drugs applied in treating neurodegenerative diseases are briefly characterized. The immobilization of enzymes, nature of the signal recorded and its dependence on the transducer modification are considered and the analytical characteristics of appropriate biosensors are summarized for donepezil, huperzine A, rivastigmine, eserine and galantamine as common anti-dementia drugs. Finally, the prospects for the application of AChE-based biosensors in clinical practice are discussed.
|
| Ключевые слова |
acetylcholinesteras, drug determination, electrochemical biosensor, reversible inhibition
|
| Название журнала |
Biosensors
|
| Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на эту карточку |
https://repository.kpfu.ru/?p_id=299582 |
Полная запись метаданных  |
| Поле DC |
Значение |
Язык |
| dc.contributor.author |
Ларина Марина Леонидовна |
ru_RU |
| dc.date.accessioned |
2024-01-01T00:00:00Z |
ru_RU |
| dc.date.available |
2024-01-01T00:00:00Z |
ru_RU |
| dc.date.issued |
2024 |
ru_RU |
| dc.identifier.citation |
Ivanov A, Shamagsumova R, Larina M, Electrochemical Acetylcholinesterase Sensors for Anti-Alzheimer?s Disease Drug Determination//Biosensors. - 2024. - Vol.14, Is.2. - Art. №93.
|
ru_RU |
| dc.identifier.uri |
https://repository.kpfu.ru/?p_id=299582 |
ru_RU |
| dc.description.abstract |
Biosensors |
ru_RU |
| dc.description.abstract |
Neurodegenerative diseases and Alzheimer's disease (AD), as one of the most common causes of dementia, result in progressive losses of cholinergic neurons and a reduction in the presynaptic markers of the cholinergic system. These consequences can be compensated by the inhibition of acetylcholinesterase (AChE) followed by a decrease in the rate of acetylcholine hydrolysis. For this reason, anticholinesterase drugs with reversible inhibition effects are applied for the administration of neurodegenerative diseases. Their overdosage, variation in efficiency and recommendation of an individual daily dose require simple and reliable measurement devices capable of the assessment of the drug concentration in biological fluids and medications. In this review, the performance of electrochemical biosensors utilizing immobilized cholinesterases is considered to show their advantages and drawbacks in the determination of anticholinesterase drugs. In addition, common drugs applied in treating neurodegenerative diseases are briefly characterized. The immobilization of enzymes, nature of the signal recorded and its dependence on the transducer modification are considered and the analytical characteristics of appropriate biosensors are summarized for donepezil, huperzine A, rivastigmine, eserine and galantamine as common anti-dementia drugs. Finally, the prospects for the application of AChE-based biosensors in clinical practice are discussed.
|
ru_RU |
| dc.language.iso |
ru |
ru_RU |
| dc.subject |
acetylcholinesteras |
ru_RU |
| dc.subject |
drug determination |
ru_RU |
| dc.subject |
electrochemical biosensor |
ru_RU |
| dc.subject |
reversible inhibition
|
ru_RU |
| dc.title |
Electrochemical Acetylcholinesterase Sensors for Anti-Alzheimer?s Disease Drug Determination//Biosensors |
ru_RU |
| dc.type |
Статьи в зарубежных журналах и сборниках |
ru_RU |
|
EN 
中文 
ES 
Карта сайта
